John Burns
Directeur Financier/CFO chez SELLAS LIFE SCIENCES GROUP, INC.
Fortune : 141 995 $ au 30/04/2024
Postes actifs de John Burns
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Comptroller/Controller/Auditor | 30/12/2017 | - |
| Directeur Financier/CFO | 30/12/2017 | - |
Historique de carrière de John Burns
Anciens postes connus de John Burns
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PIXELWORKS, INC. | Corporate Officer/Principal | - | - |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | 23/02/2016 | - |
Formation de John Burns
| Tulane University (Louisiana) | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Comptroller/Controller/Auditor | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PIXELWORKS, INC. | Electronic Technology |
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Bourse
- Insiders
- John Burns
- Expérience
